AutismInsights
Back to Intervention Library

Pharmacological

Risperidone

Limited Evidence13 linked studiesCompare with another

What is Risperidone?

Atypical antipsychotic medication approved for treating irritability in autistic children.

Evidence Summary

Risperidone has been studied 13 times for autism support, though notably with zero total participants reported across these studies. Evidence grades show 6 limited studies, 5 emerging studies, and 2 moderate-quality studies. This mixed evidence suggests researchers are still working to understand risperidone's role in autism care. Parents considering this option should discuss potential benefits and risks with their healthcare provider, as the current research base remains developing.

Evidence last reviewed: 21 July 2026

Linked Studies (13)

EmergingCase Report

Acute Pisa syndrome in a 4-year-old child with autism spectrum disorder: The youngest reported case of risperidone-induced extrapyramidal reaction.

Asian journal of psychiatry2026

Garg Himanshu, Pandey Abhishek, Anushree Neha et al.

Plain-English summary

A 4-year-old boy with autism taking risperidone for behavior issues developed a rare side effect called Pisa syndrome, causing his trunk to bend sideways painfully. This was the youngest case ever reported. Doctors treated him with medication that immediately fixed the problem, stopped the risperidone, and he fully recovered. Parents should know that even young children can experience unusual side effects from autism medications.

Summary by AutismInsights from published abstract.

Emerging

Comparative Analysis of Cannabidiol and Risperidone on Behavioral and Neurochemical Outcomes, and Neurodevelopment Markers in a Zebrafish Model of Embryonic Exposure to Sodium Valproate.

Autism research : official journal of the International Society for Autism Research2025

Costa Karla C M, Brigante Tamires A V, Lirio Pedro H C et al.

Plain-English summary

Researchers used zebrafish to study whether CBD (a compound from cannabis) or risperidone (an antipsychotic medication) could help with autism-like behaviors. They found CBD was more effective at reducing hyperactivity and aggression, and better at protecting the brain from damage. Risperidone was less effective. While this is early animal research, it suggests CBD might be worth studying further as a potential treatment.

Summary by AutismInsights from published abstract.

EmergingRandomised Controlled Trial

Efficacy and safety of risperidone and aripiprazole in reducing severity of irritability in children with autism spectrum disorder: A randomized controlled trial.

Brain & development2025

Panda Prateek Kumar, Sharawat Indar Kumar, Gupta Diksha et al.

Plain-English summary

This study compared two medications (risperidone and aripiprazole) for reducing irritability and challenging behaviours in 72 autistic children aged 6-18. Both medications worked equally well at reducing irritability, improving sleep, and helping with other behaviours. Side effects were similar for both medications, but risperidone increased prolactin hormone levels while aripiprazole decreased them. Parents can discuss with doctors that both medications appear to be equally effective options.

Summary by AutismInsights from published abstract.

Emerging

External validation of a therapeutic window for risperidone in children with autism spectrum disorder.

British journal of clinical pharmacology2025

Hermans Rebecca A, Bruens Kathalijne, Egberts Karin M et al.

Plain-English summary

This research checked how well doctors can predict the right amount of risperidone medication for autistic children. Risperidone helps manage challenging behaviors but can cause side effects. The study confirmed that blood level measurements between 3.5-7.0 ng/mL work well for treatment monitoring, helping doctors give the right dose while avoiding harmful effects.

Summary by AutismInsights from published abstract.

Emerging

Dopamine disruption and autism phenotypes in slc6a3-/- zebrafish: Behavioural and molecular insights.

Progress in neuro-psychopharmacology & biological psychiatry2025

Li Wen, Zhang Xiaocong, Niu Xiaoyu et al.

Plain-English summary

Scientists created genetically modified zebrafish that couldn't properly process dopamine, a brain chemical important for movement and emotions. These fish showed autism-like behaviors such as being less active, more anxious, and having trouble with social interactions. When treated with certain medications (risperidone and clozapine), the fish improved. This research helps us understand how dopamine problems might contribute to autism and provides a way to test new treatments.

Summary by AutismInsights from published abstract.

Emerging

Recalculation of the budgetary impact of risperidone use for Autism Spectrum Disorder: a case study using measured demand data, Brazil, 2017-2019.

Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil2025

Lopes Luis Phillipe Nagem, Raimundo Augusto César Sousa, Itria Alexander et al.

Plain-English summary

This study looked at how much money Brazil's health system actually spent on risperidone (a medication sometimes used for autism) compared to what they thought they would spend. The real costs were much higher than predicted - about 50-60% more than expected for both children and adults with autism. This shows that predicting healthcare costs can be difficult and that demand for autism medications might be higher than health officials initially think.

Summary by AutismInsights from published abstract.

Emerging

Effects of Cannabidiol Isolated or in Association With Risperidone in an Animal Model of Autism.

Developmental neurobiology2025

Costa Maiara de Aguiar da, Fernandes Gustavo Zanette, Maiochi Eduarda et al.

Plain-English summary

Researchers studied whether cannabidiol (CBD) could help with autism symptoms in rats. They gave pregnant rats a chemical that causes their babies to have autism-like behaviors, then treated the baby rats with CBD alone or CBD combined with risperidone (an autism medication). CBD by itself didn't help social behavior, but CBD combined with risperidone improved how well the rats interacted socially. This is early animal research, so more studies are needed before knowing if this applies to people.

Summary by AutismInsights from published abstract.

EmergingReview

Retracing our steps: A review on autism research in children, its limitation and impending pharmacological interventions.

Pharmacology & therapeutics2024

Salloum-Asfar Salam, Zawia Nasser, Abdulla Sara A

Plain-English summary

This review looks at current autism treatments and research gaps. While there are no medications specifically for autism's main symptoms (communication, social skills, repetitive behaviors), doctors can prescribe medications for related issues like aggression, ADHD, and sleep problems. The authors stress that better diagnostic tests and personalized treatments are urgently needed to help children with autism more effectively.

Summary by AutismInsights from published abstract.

Emerging

The Frequency of CYP2D6 and CYP3A4/5 Genotypes and The Impact of Their Allele Translation and Phenoconversion-Predicted Enzyme Activity on Risperidone Pharmacokinetics in Saudi Children with Autism.

Biochemical genetics2024

Shilbayeh Sireen Abdul Rahim, Adeen Iman Sharaf, Alhazmi Ayman Shawqi et al.

Plain-English summary

This study looked at how genetic differences affect how children with autism process risperidone medication. Researchers tested 83 Saudi children and found that certain genetic variations influenced how quickly the body breaks down risperidone, but these differences didn't affect the overall medication effectiveness. The findings suggest that other genetic factors, not yet identified, may also play important roles in how children respond to this medication.

Summary by AutismInsights from published abstract.

EmergingRandomised Controlled Trial

Effect of Adding l -Carnitine to Risperidone on Behavioral, Cognitive, Social, and Physical Symptoms in Children and Adolescents With Autism: A Randomized Double-Blinded Placebo-Controlled Clinical Trial.

Clinical neuropharmacology2023

Shakibaei Fereshteh, Jelvani Danial

Plain-English summary

This study looked at whether adding L-carnitine (a natural supplement) to risperidone medication helps children with autism. 50 children were split into two groups - one got L-carnitine plus risperidone, the other got a fake pill plus risperidone. After 8 weeks, children taking L-carnitine showed improvements in behavior problems, social withdrawal, repetitive behaviors, and speech issues compared to those taking the fake pill.

Summary by AutismInsights from published abstract.

Emerging

The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy.

Psychopharmacology2023

Atia Amany Aa, Ashour Rehab H, Zaki Marwa Maf et al.

Plain-English summary

Researchers tested two medications - metformin (a diabetes drug) and risperidone (an autism-approved medication) - in rats with autism-like behaviors. Both medications helped reduce anxiety, social problems, and repetitive behaviors. The study found that these medications work by improving a brain cleaning process called autophagy in the hippocampus (memory center). Metformin was more effective at improving this brain cleaning process than risperidone, which may explain why it worked better overall.

Summary by AutismInsights from published abstract.

Emerging

Risperidone impedes glutamate excitotoxicity in a valproic acid rat model of autism: Role of ADAR2 in AMPA GluA2 RNA editing.

European journal of pharmacology2023

Habib Mohamed Z, Elnahas Esraa M, Aboul-Ela Yasmin M et al.

Plain-English summary

Researchers studied how the medication risperidone works in rats with autism-like behaviors. They found that autism-related brain changes involved problems with how brain cells process a chemical messenger called glutamate. Risperidone helped fix these problems and improved the rats' behavior. This gives scientists new ideas about how risperidone might help people with autism.

Summary by AutismInsights from published abstract.

Emerging

Novel role of peroxisome proliferator activated receptor-α in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination.

Progress in neuro-psychopharmacology & biological psychiatry2022

Elnahas Esraa M, Abuelezz Sally A, Mohamad Magda I et al.

Plain-English summary

Scientists studied autism-like behaviors in rats by giving pregnant mothers valproic acid. They then treated the baby rats with two medications - metformin and risperidone - either alone or together. Both treatments helped reduce autism-like behaviors and brain changes. Metformin worked as well as risperidone and helped prevent weight gain that risperidone can cause. The study suggests these medications might work by activating specific brain pathways.

Summary by AutismInsights from published abstract.

Related Interventions

AutismInsights presents published research for informational purposes only. This is not medical advice. Always consult your child's paediatrician, psychologist, or allied health team before making decisions about therapies or interventions.